Versant Venture Management, Llc Portfolio Stock Holdings
Versant Venture Management, Llc disclosed 8 stock positions valued at approximately $141.4 million in its latest SEC 13F filing. The largest holdings include Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc., and Lenz Therapeutics, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 5, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 8
- Portfolio Value
- $141.4M
Holdings by Sector
Versant Venture Management, Llc Portfolio Holdings in Q1 2026
6 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | GLUE | Healthcare | 37.00% | 3,180,780 | -1,201,907 | -27.42% | $52,323,831 |
| Century Therapeutics, Inc. | IPSC | Healthcare | 19.44% | 12,166,109 | +12,166,109 | +100.00% | $27,495,406 |
| Lenz Therapeutics, Inc. | LENZ | Healthcare | 17.19% | 2,656,888 | - | - | $24,310,525 |
| Contineum Therapeutics, Inc. | CTNM | Healthcare | 5.01% | 542,628 | - | - | $7,086,722 |
| Skye Bioscience, Inc. | SKYE | Healthcare | 0.87% | 2,007,704 | - | - | $1,233,935 |
| Tempest Therapeutics, Inc. | TPST | Healthcare | 0.31% | 269,772 | - | - | $442,426 |